The view from two sides: A qualitative study of community and medical perspectives on screening for colorectal cancer using FOBT

Preventive Medicine

Volumn 39, Issue 3, 2004, Pages 482-490

  Clavarino, Alexandra M ^a   Janda, Monika ^b,c   Hughes, Karen L ^b   Del Mar, Christopher ^a   Tong, Shilu ^b   Stanton, Warren R ^a   Aitken, Joanne F ^c   Leggett, Barbara A ^d   Newman, Beth ^b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^c Sunshine Coast Mind and Neuroscience Thompson Institute   (Australia)

^d ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

Colorectal cancer; FOBT; Qualitative research; Screening

Indexed keywords

ADULT; AGED; CANCER SCREENING; COLORECTAL CANCER; CONTROLLED STUDY; GENERAL PRACTITIONER; HEALTH CARE COST; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; MASS SCREENING; OCCULT BLOOD TEST; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; REVIEW;

EID: 4143092523     PISSN: 00917435     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ypmed.2004.05.015     Document Type: Article

References (44)

1. Australian Health Technology Advisory Committee (AHTAC) Colorectal cancer screening. 1997;AGPS, Canberra
2. Pederson K.E., Elwood M. Current international developments in population screening for colorectal cancer. Aust. N. Z. J. Surg. 72:2002;507-512
3. http://www.health.gov.au/pcd/campaigns/bowell/index.htm, accessed 26/02/2004.
4. Collett J.A., Olynk J.K. Colorectal cancer screening in average-risk asymptomatic Australians. Med. J. Aust. 169:1998;14-15
5. Australian Institute of Health and Welfare (AIHW) and Australasian Association of Cancer Registries (AACR). Cancer in Australia 2000. AIHW Cat No. CAN 18. Canberra: AIHW, 2003 [Cancer Series no.23].
6. Vernon S.W. Participation in colorectal cancer screening: a review. J. Natl. Cancer Inst. 89:1997;1406-1422
7. Box V., Nichols S., Lallemand R.C., Pearson P., Vakil P.A. Haemoccult compliance rates and reasons for non-compliance. Public Health. 98:1984;16-25
8. Wender R.C. Barriers to screening for colorectal cancer. Gastrointest. Endosc. Clin. N. Am. 12(1):2002;145-170
9. Macrae F.A. Screening for colorectal cancer, 1996. Med. J. Aust. 165:1996;102-105
10. Neilson A.R., Whynes D.K. Determinants of persistent compliance with screening for colorectal cancer. Soc. Sci. Med. 3:1995;365-374
11. Hiatt R.A. Behavioral research contributions and needs in cancer prevention and control: adherence to cancer screening advice. Prev. Med. 26:1997;S11-S18
12. Thomas R.J., Clarke V.A. Colorectal cancer: a survey of community beliefs and behaviours in Victoria. Med. J. Aust. 169:1998;37-40
13. Cole S.R., Young G.P. Effect of dietary restriction on participation in faecal occult blood test screening for colorectal cancer. Med. J. Aust. 175(4):2001;195-198
14. Arveux P., Durand G., Milan C., et al. Views of a general population on mass screening for colorectal cancer: the Burgundy Study. Prev. Med. 21:1992;574-581
15. Klaaborg K., Madsen M.S., Sondergaard O., Kronborg O. Participation in mass screening for colorectal cancer with fecal occult blood test. Scand. J. Gastroenterol. 21:1986;1180-1184
16. Hynam K.A., Hart A.R., Gray S.P., Inglis A., Wicks A.C.B., Mayberry J.F. Screening for colorectal cancer: Reasons for refusal of faecal occult blood testing in a general practice in England. J. Epidemiol. Community Health. 49:1995;84-86
17. Janda M., Stanton W.R., Hughes K., et al. Intention to use a faecal occult blood test for colorectal cancer screening among rural residents with and without a family history. Asia Pac. J. Public Health. 15(1):2003;50-56
18. Lowe J.B., Balanda K.P., Gillespie A.M., Stanton W.R., Anderson P.J. Community perceptions of bowel cancer: a survey of Queenslanders. Health Educ. J. 54:1995;331-339
19. McCaffery K., Borril J., Williamson S., et al. Declining the offer of flexible sigmoidoscopy screening for bowel cancer: a qualitative investigation of the decision-making process. Soc. Sci. Med. 53:2001;679-691
20. Goyder E., Barrat A., Irwig L.M. Telling people about screening programmes and screening test results: how can we do better? J. Med. Screen. 2000;123-126
21. Janda M., Hughes K., Tong S., et al. Faecal occult blood test: current practice in a rural Queensland community. Aust. J. Rural Health. 10:2002;57-64
22. Paul C., Tzelepis F., Walsh R.A., et al. Has the investment in public cancer education delivered observable changes in knowledge over the past 10 years? Cancer. 97:2003;2931-2939
23. Sladden M.J., Ware J.E. Australian general practitioners' views and use of colorectal cancer screening tests. Med. J. Aust. 170:1999;110-113
24. Colquhoun P., Newstead G., Weiss E.G., et al. Colorectal cancer screening: do they practice what they preach? Aust. N. Z. J. Surg. 73:2003;1028-1031
25. Patton M.Q. How to use qualitative methods in evaluation. 1987;Sage, Newbury Park
26. Miles M.B., Huberman A.M. Qualitative data analysis: an expanded sourcebook. second ed.:1994;Sage, Thousand Oaks
27. Clavarino A.M., Najman J.M., Silverman D. The quality of qualitative data: two strategies for analysing medical interviews. Qual. Inq. 1:1995;223-242
28. Howard K., Salkeld G. Home bowel cancer tests and informed choice - Is current information sufficient? Aust. N. Z. J. Public Health. 27(5):2003;513-516
29. King J., Fairbrother G., Thompson C., Morris D.L. Colorectal cancer screening: optimal compliance with postal faecal occult blood test. Aust. N. Z. J. Surg. 62:1992;714-719
30. Cole S.R., Young G.P., Byrne D., Guy J.R., Morcom J. Participation in screening for colorectal cancer based on a faecal occult blood test is improved by endorsement by the primary care practitioner. J. Med. Screen. 9:2002;147-152
31. Young G.P. Australian trends in colorectal cancer incidence and Australian guidelines for prevention. Eur. J. Cancer Prev. 8:1999;179-181
32. Weitzman E.R., Zapka J., Estabrook B., Goins K.V. Risk and reluctance: understanding impediments to colorectal cancer screening. Prev. Med. 32:2001;502-513
33. Launoy G., Veret J.-L., Richir G., et al. Involvement of general practitioners in mass screening. Experience of a colorectal cancer mass screening programme in the Calvados region (France). Eur. J. Cancer Prev. 2:1993;229-232
34. Cameron L. Screening for cancer: illness perceptions and illness worry. Weinman J.A., Petrie K.J. Perceptions of health and illness. 1997;Harwood Academic, The Netherlands
35. Davison C., Davey Smith G., Frankel S. Lay epidemiology and the prevention paradox: the implications of coronary candidacy for health education. Sociol. Health Illn. 13:1991;1-19
36. Hart A.R., Wicks A.C., Mayberry J.F. Colorectal cancer screening in asymptomatic populations. Gut. 36:1995;590-598
37. Geller A.C., Zhang Z., Sober A.J., et al. The first 15 years of the American academy of dermatology skin cancer screening programs: 1985-1999. J. Am. Acad. Dermatol. 48:2003;34-41
38. Halabi S., Skinner C.S., Samsa G.P., Strigo T.S., Crawford Y.S., Rimer B.K. Factors associated with repeated mammography screening. J. Fam. Pract. 49:2000;1104-1112
39. Wardle J., Taylor T., Sutton S., Atkin W. Does publicity about cancer screening raise fear of cancer? Randomised trial of the psychological side effect of information about cancer screening. Br. Med. J. 319:1999;1037-1038
40. Bolin T.D., Lapsley H.M., Korman M.G. Screening for colorectal cancer: what is the most cost-effective approach? Med. J. Aust. 174:2001;298-301
41. Eaden J., Mayberry M.K., Sherr A., Mayberry J.F. Screening: the legal view. Public Health. 115:2001;218-221
42. NHMRC. National Health and Medical Research Council. Guidelines for the prevention, early detection and management of Colorectal Cancer (CRC). NHMRC, 1999.
43. Jepson R.G., Forbes C.A., Sowden A.J., Lewis R.A. Increasing informed uptake and non-uptake of screening: evidence from a systematic review. Health Expect. 4:2001;116-130
44. Salkeld G., Solomon M., Short L., et al. Evidence-based consumer choice: a case study in colorectal cancer screening. Aust. N. Z. J. Public Health. 27(4):2003;449-455